
Qingdao
603739.SSQingdao Vland Biotech INC. Price (603739.SS)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
252,209,098
(2.4993)%Income Statement Summary
Revenue | |
Cost of Revenue | |
Gross Profit | |
Operating Expenses | |
Operating Income | |
Other Expenses | |
Net Income |


Income Statement
Qingdao Vland Biotech INC.Currency: CNY
YEAR | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | |||||||||||||||||||
Revenue |
728,223,334.00
+0% |
751,723,670.00
+3% |
781,229,944.00
+4% |
799,439,774.00
+2% |
813,970,528.00
+2% |
846,777,962.00
+4% |
960,249,354.00
+13% |
1,150,823,565.00
+20% |
1,163,162,781.00
+1% |
1,198,902,103.00
+3% |
|||||||||
Cost of Revenue | |||||||||||||||||||
Cost of Revenue | 326,571,497.00 | 359,649,256.00 | 353,971,565.00 | 384,612,066.00 | 409,564,772.00 | 437,069,124.00 | 492,334,325.00 | 618,507,475.00 | 660,311,201.00 | 644,687,499.00 | |||||||||
Gross Profit | |||||||||||||||||||
Gross Profit |
401,651,837.00
+0% |
392,074,414.00
-2% |
427,258,379.00
+9% |
414,827,708.00
-3% |
404,405,756.00
-3% |
409,708,838.00
+1% |
467,915,029.00
+14% |
532,316,090.00
+14% |
502,851,580.00
-6% |
554,214,604.00
+10% |
|||||||||
Gross Profit Ratio | (0.55%) | (0.52%) | (0.55%) | (0.52%) | (0.50%) | (0.48%) | (0.49%) | (0.46%) | (0.43%) | (0.46%) | |||||||||
Operating Expenses | |||||||||||||||||||
Research and Development | 97,970,500.00 | 83,258,834.00 | 77,478,363.00 | 70,615,521.00 | 69,693,177.00 | 74,997,959.00 | 79,913,467.00 | 100,936,653.00 | 102,396,593.00 | 110,681,959.00 | |||||||||
General and Administrative | 186,730,486.00 | 20,665,069.00 | 19,715,835.00 | 26,137,607.00 | 21,247,701.00 | 27,321,551.00 | 24,958,418.00 | 30,751,235.00 | 33,579,048.00 | 30,814,249.00 | |||||||||
Selling, General & Admin... | 329,209,537.00 | 162,784,121.00 | 168,268,060.00 | 173,888,416.00 | 162,969,570.00 | 199,823,866.00 | 188,236,351.00 | 210,327,630.00 | 210,394,661.00 | 327,445,050.00 | |||||||||
Selling & Marketing Exp... | 142,479,051.00 | 142,119,051.00 | 148,552,225.00 | 147,750,808.00 | 141,721,868.00 | 172,502,315.00 | 163,277,932.00 | 179,576,394.00 | 176,815,612.00 | 134,070,828.00 | |||||||||
Depreciation and Amortiz... | 31,689,900.00 | 34,456,343.00 | 34,374,700.00 | 35,380,500.00 | 35,689,670.00 | 37,963,859.00 | 43,086,803.00 | 51,898,128.00 | 66,657,706.00 | 74,284,185.00 | |||||||||
Other Expenses | 33,173,133.00 | 30,316,203.00 | 19,542,062.00 | 2,914,572.00 | 2,748,409.00 | 41,202,841.00 | 50,094,696.00 | 45,003,198.00 | 64,719,652.00 | -3,257,569.00 | |||||||||
Total Operating Expenses | 334,641,781.00 | 314,582,510.00 | 318,667,934.00 | 294,973,628.00 | 288,697,956.00 | 316,024,667.00 | 318,244,515.00 | 356,267,482.00 | 377,510,907.00 | 431,313,998.00 | |||||||||
Cost and Exponses | 661,213,278.00 | 674,231,767.00 | 672,639,500.00 | 679,585,695.00 | 698,262,729.00 | 753,093,792.00 | 810,578,840.00 | 974,774,957.00 | 1,037,822,108.00 | 1,076,001,498.00 | |||||||||
Operating Income | |||||||||||||||||||
Operating Income |
46,596,627.00
+0% |
68,438,005.00
+47% |
94,680,648.00
+38% |
115,119,072.00
+22% |
108,987,969.00
-5% |
97,790,280.00
-10% |
142,063,360.00
+45% |
170,868,102.00
+20% |
102,903,965.00
-40% |
122,900,605.00
+19% |
|||||||||
Operating Income Ratio | (0.06%) | (0.09%) | (0.12%) | (0.14%) | (0.13%) | (0.12%) | (0.15%) | (0.15%) | (0.09%) | (0.10%) | |||||||||
Other Income and Exp... | |||||||||||||||||||
Interest Income | 1,370,726.00 | 215,122.00 | 314,591.00 | 320,627.00 | 188,260.00 | 489,361.00 | 461,445.00 | 714,626.00 | 658,184.00 | 452,872.00 | |||||||||
Interest Expenses | 0.00 | 6,265,546.00 | 4,337,323.00 | 2,570,081.00 | 4,355,419.00 | 1,881,137.00 | 1,776,108.00 | 2,122,720.00 | 7,171,788.00 | 15,218,209.00 | |||||||||
Total Other Income/Exp... | 32,793,934.00 | 29,443,450.00 | 19,310,714.00 | 2,093,263.00 | 2,748,410.00 | -183,772.00 | -1,914,695.00 | 534,969.00 | -716,734.00 | -405,451.00 | |||||||||
EBITDA | |||||||||||||||||||
EBITDA | 77,143,658.00 | 138,984,998.00 | 153,077,241.00 | 155,627,141.00 | 152,242,737.00 | 137,752,319.00 | 185,602,979.00 | 226,330,059.00 | 179,650,067.00 | 217,901,471.00 | |||||||||
EBITDA ratio | (0.17%) | (0.20%) | (0.21%) | (0.20%) | (0.19%) | (0.16%) | (0.20%) | (0.20%) | (0.17%) | (0.18%) | |||||||||
Income Before Tax | |||||||||||||||||||
Income Before Tax | 79,390,558.00 | 97,881,455.00 | 113,991,362.00 | 117,212,335.00 | 111,736,379.00 | 97,606,508.00 | 140,148,663.00 | 171,403,071.00 | 102,187,225.00 | 122,495,154.00 | |||||||||
Income Before Tax Ratio | (0.11%) | (0.13%) | (0.15%) | (0.15%) | (0.14%) | (0.12%) | (0.15%) | (0.15%) | (0.09%) | (0.10%) | |||||||||
Income Tax Expense | |||||||||||||||||||
Income Tax Expense | 19,739,857.00 | 20,207,545.00 | 24,501,344.00 | 24,682,195.00 | 18,797,327.00 | 8,215,073.00 | 17,843,886.00 | 21,305,803.00 | 16,775,933.00 | 19,637,913.00 | |||||||||
Net Income | |||||||||||||||||||
Net Income | 53,234,920.00
+0% |
70,265,775.00
+32% |
82,550,442.00
+17% |
85,625,176.00
+4% |
83,384,938.00
-3% |
77,752,946.00
-7% |
108,976,210.00
+40% |
132,573,196.00
+22% |
69,842,007.00
-47% |
80,706,911.00
+16% |
|||||||||
Net Income Ratio | (0.07%) | (0.09%) | (0.11%) | (0.11%) | (0.10%) | (0.09%) | (0.11%) | (0.12%) | (0.06%) | (0.07%) | |||||||||
Earning Per Share | |||||||||||||||||||
Basic EPS | 0.33 | 0.44 | 0.51 | 0.53 | 0.51 | 0.36 | 0.50 | 0.54 | 0.28 | 0.32 | |||||||||
Diluted EPS | 0.33 | 0.44 | 0.51 | 0.53 | 0.51 | 0.36 | 0.50 | 0.54 | 0.27 | 0.32 | |||||||||
Share Outstanding | |||||||||||||||||||
Basic Share Outstanding | 162,005,243.00 | 161,265,713.00 | 162,775,520.00 | 161,984,824.00 | 162,132,885.00 | 216,533,803.00 | 216,533,803.00 | 245,505,919.00 | 252,441,726.00 | 252,209,098.00 | |||||||||
Diluted Share Outstanding | 162,019,323.00 | 161,265,713.00 | 162,775,520.00 | 161,993,577.00 | 162,137,381.00 | 216,533,803.00 | 216,533,803.00 | 245,505,919.00 | 258,674,102.00 | 252,209,098.00 |